Literature DB >> 16507910

Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.

Kunihiro Uryu1, Christiane Richter-Landsberg, William Welch, Eveline Sun, Olaf Goldbaum, Erin H Norris, Chi-Tuan Pham, Ikuru Yazawa, Kristen Hilburger, Matthew Micsenyi, Benoit I Giasson, Nancy M Bonini, Virginia M-Y Lee, John Q Trojanowski.   

Abstract

Heat shock proteins (Hsps) facilitate refolding of denatured polypeptides, but there is limited understanding about their roles in neurodegenerative diseases characterized by misfolded proteins. Because Parkinson's disease (PD), dementia with Lewy bodies, and multiple system atrophy are alpha-synucleinopathies characterized by filamentous alpha-synuclein (alpha-syn) inclusions, we assessed which Hsps might be implicated in these disorders by examining human brain samples, transgenic mouse models, and cell culture systems. Light and electron microscopic multiple-label immunohistochemistry showed Hsp90 was the predominant Hsp examined that co-localized with alpha-syn in Lewy bodies, Lewy neurites, and glial cell inclusions and that Hsp90 co-localized with alpha-syn filaments of Lewy bodies in PD. Hsp90 levels were most predominantly increased in PD brains, which correlated with increased levels of insoluble alpha-syn. These alterations in Hsp90 were recapitulated in a transgenic mouse model of PD-like alpha-syn pathologies. Cell culture studies also revealed that alpha-syn co-immunoprecipitated preferentially with Hsp90 and Hsc70 relative to other Hsps, and exposure of cells to proteasome inhibitors resulted in increased levels of Hsp90. These data implicate predominantly Hsp90 in the formation of alpha-syn inclusions in PD and related alpha-synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507910      PMCID: PMC1606542          DOI: 10.2353/ajpath.2006.050770

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  68 in total

Review 1.  The ubiquitin-proteasome pathway and pathogenesis of human diseases.

Authors:  A L Schwartz; A Ciechanover
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

2.  Developmental regulation of alternatively spliced isoforms of mRNA encoding MAP2 and tau in rat brain oligodendrocytes during culture maturation.

Authors:  C Richter-Landsberg; M Gorath
Journal:  J Neurosci Res       Date:  1999-05-01       Impact factor: 4.164

Review 3.  Chaperone-mediated protein folding.

Authors:  A L Fink
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

4.  Double immunolabeling of neuropeptides in the human hypothalamus as analyzed by confocal laser scanning fluorescence microscopy.

Authors:  H J Romijn; J F van Uum; I Breedijk; J Emmering; I Radu; C W Pool
Journal:  J Histochem Cytochem       Date:  1999-02       Impact factor: 2.479

5.  The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.

Authors:  P G Galloway; C Bergeron; G Perry
Journal:  Neurosci Lett       Date:  1989-05-22       Impact factor: 3.046

6.  Distribution of tau proteins in the normal human central and peripheral nervous system.

Authors:  J Q Trojanowski; T Schuck; M L Schmidt; V M Lee
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

7.  Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue.

Authors:  S A Schnell; W A Staines; M W Wessendorf
Journal:  J Histochem Cytochem       Date:  1999-06       Impact factor: 2.479

8.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

Authors:  M Baba; S Nakajo; P H Tu; T Tomita; K Nakaya; V M Lee; J Q Trojanowski; T Iwatsubo
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

9.  Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species.

Authors:  Matthew M Dedmon; John Christodoulou; Mark R Wilson; Christopher M Dobson
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

10.  Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila.

Authors:  Pavan K Auluck; Marc C Meulener; Nancy M Bonini
Journal:  J Biol Chem       Date:  2004-11-18       Impact factor: 5.157

View more
  65 in total

Review 1.  Molecular chaperones in Parkinson's disease--present and future.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

2.  Heat shock protein responses to aging and proteotoxicity in the olfactory bulb.

Authors:  Tyler S Crum; Amanda M Gleixner; Jessica M Posimo; Daniel M Mason; Matthew T Broeren; Scott D Heinemann; Peter Wipf; Jeffrey L Brodsky; Rehana K Leak
Journal:  J Neurochem       Date:  2015-03-05       Impact factor: 5.372

3.  Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip.

Authors:  Cintia Roodveldt; Carlos W Bertoncini; August Andersson; Annemieke T van der Goot; Shang-Te Hsu; Rafael Fernández-Montesinos; Jannie de Jong; Tjakko J van Ham; Ellen A Nollen; David Pozo; John Christodoulou; Christopher M Dobson
Journal:  EMBO J       Date:  2009-10-29       Impact factor: 11.598

4.  Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism.

Authors:  Juhi Ojha; Gunasingh Masilamoni; David Dunlap; Ross A Udoff; Anil G Cashikar
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

5.  Identification of chaperones in a MPP+-induced and ATRA/TPA-differentiated SH-SY5Y cell PD model.

Authors:  Hongrong Xie; Hui Hu; Ming Chang; Dongya Huang; Xiaobo Gu; Xinli Xiong; Ran Xiong; Linsen Hu; Gang Li
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 6.  Molecular chaperones and co-chaperones in Parkinson disease.

Authors:  Hemi Dimant; Darius Ebrahimi-Fakhari; Pamela J McLean
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

Review 7.  Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.

Authors:  Tessa Sinnige; Anan Yu; Richard I Morimoto
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases.

Authors:  Mathew B Wong; Jacob Goodwin; Anwar Norazit; Adrian C B Meedeniya; Christiane Richter-Landsberg; Wei Ping Gai; Dean L Pountney
Journal:  Neurotox Res       Date:  2012-11-15       Impact factor: 3.911

9.  The Small Heat Shock Protein HSP25/27 (HspB1) Is Abundant in Cultured Astrocytes and Associated with Astrocytic Pathology in Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  Lisa Schwarz; Grit Vollmer; Christiane Richter-Landsberg
Journal:  Int J Cell Biol       Date:  2010-01-27

10.  17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy.

Authors:  Michael Riedel; Olaf Goldbaum; Lisa Schwarz; Sebastian Schmitt; Christiane Richter-Landsberg
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.